Patent ID: 11939335
Assignee: 858 THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC A  C

Claim 10:
11. The compound of claim 9, or a pharmaceutically acceptable salt, deuteroisotope, or stereoisomer thereof, wherein R1 is CD2(heteroaryl), wherein the heteroaryl portion of CD2(heteroaryl) is optionally substituted with one or more substituents independently selected from the group consisting of D, halo, CN, NO2, alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, C(O)Ra, C(O)N(Ra)2, C(O)ORa, N(Ra)2, NRaC(O)Ra, NRaC(O)ORa, NRaS(O)tRa, ORa, OC(O)Ra, OC(O)N(Ra)2, OC(O)ORa, ORcC(O)N(Ra)2, S(O)tRa, S(O)tN(Ra)2, S(O)tORa, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl.